CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 99 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,999,084 | +57.0% | 171,008 | +80.5% | 0.01% | +66.7% |
| Q2 2023 | $1,273,359 | +86.1% | 94,744 | +129.6% | 0.00% | +50.0% |
| Q1 2023 | $684,190 | -10.9% | 41,266 | -0.1% | 0.00% | 0.0% |
| Q4 2022 | $767,994 | +19099.8% | 41,290 | +19561.9% | 0.00% | – |
| Q3 2022 | $4,000 | -50.0% | 210 | -80.1% | 0.00% | – |
| Q2 2022 | $8,000 | -99.9% | 1,053 | -99.8% | 0.00% | -100.0% |
| Q1 2022 | $5,442,000 | +22.2% | 656,372 | -0.2% | 0.01% | +50.0% |
| Q4 2021 | $4,452,000 | +27.8% | 657,454 | +0.0% | 0.01% | +14.3% |
| Q3 2021 | $3,483,000 | -3.4% | 657,239 | +4.8% | 0.01% | 0.0% |
| Q2 2021 | $3,605,000 | +24.7% | 626,997 | +0.0% | 0.01% | +16.7% |
| Q1 2021 | $2,890,000 | +36.9% | 626,878 | -0.8% | 0.01% | +50.0% |
| Q4 2020 | $2,111,000 | +12.3% | 631,851 | -0.2% | 0.00% | 0.0% |
| Q3 2020 | $1,879,000 | -27.3% | 632,832 | +13.1% | 0.00% | -33.3% |
| Q2 2020 | $2,585,000 | +157.2% | 559,447 | +114.2% | 0.01% | +100.0% |
| Q1 2020 | $1,005,000 | +2771.4% | 261,196 | +2695.9% | 0.00% | – |
| Q4 2019 | $35,000 | -94.6% | 9,342 | -92.4% | 0.00% | -100.0% |
| Q3 2019 | $652,000 | +9214.3% | 122,717 | +6219.1% | 0.00% | – |
| Q2 2019 | $7,000 | +250.0% | 1,942 | +225.3% | 0.00% | – |
| Q4 2017 | $2,000 | -100.0% | 597 | -100.0% | 0.00% | -100.0% |
| Q1 2016 | $5,957,000 | -46.9% | 5,091,120 | +11.1% | 0.02% | -50.0% |
| Q4 2015 | $11,227,000 | -18.3% | 4,582,320 | 0.0% | 0.04% | -18.2% |
| Q3 2015 | $13,747,000 | -27.1% | 4,582,320 | +0.4% | 0.04% | -22.8% |
| Q2 2015 | $18,848,000 | +119.3% | 4,563,800 | +129.9% | 0.06% | +119.2% |
| Q1 2015 | $8,595,000 | +101.7% | 1,985,000 | +38.3% | 0.03% | +100.0% |
| Q4 2014 | $4,262,000 | -57.9% | 1,435,000 | -52.9% | 0.01% | -60.6% |
| Q3 2014 | $10,121,000 | +25.6% | 3,048,500 | -4.3% | 0.03% | +32.0% |
| Q2 2014 | $8,058,000 | +9.1% | 3,185,000 | -2.5% | 0.02% | 0.0% |
| Q1 2014 | $7,384,000 | +16.3% | 3,267,000 | +0.4% | 0.02% | +13.6% |
| Q4 2013 | $6,347,000 | -36.7% | 3,254,960 | -0.9% | 0.02% | -43.6% |
| Q3 2013 | $10,020,000 | +179.1% | 3,285,000 | -18.6% | 0.04% | +178.6% |
| Q2 2013 | $3,590,000 | – | 4,034,207 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
| Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
| Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
| CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
| Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
| Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
| AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
| KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |